Delivery Order SPE2DB22D3501-SPE2DB24FWP08

Award Date 8/8/24
Potential Completion Date 8/9/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,998.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. The contract covers the delivery of 4563248304 units of SOL IV 0.9% NACL 50ML 1 DS PWDR DRG VL, a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,654.16 fixed-price delivery order is for the supply of 4567222493 - SOL IV 0.9% NACL 100ML 1 DS PWDR DRG VL, with a completion date of February 11, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,707.50, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The award is a delivery order (SPE2DX15D1208|SPE2DX24FLATF) with a firm fixed price of $1,151.03 and an ultimate completion date of March 22, 2024. The contract is for the supply of a pharmaceutical product, 4564035814 ! SOL IV 0.9% NACL 500ML PLS CNTNR VFLX LF, to support military treatment...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a for-profit organization. The $1,241.30 firm fixed price delivery order is for the supply of 4565076088 - SOL IV 0.9% NACL 100ML 1 DS PWDR DRG VL, with a period of performance through July 8, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award, with a ceiling value of $2,205.44, is for the delivery of 4562720248 ! SOL IV 0.9% NACL 500ML PLS CNTNR VFLX LF medical supplies. The contract has an ultimate completion date of November 7, 2023 and is a Delivery Order under a Firm Fixed Price contract type. There is no set-aside designation, indicating the...
The U.S. government awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a Firm Fixed Price Delivery Order contract valued at $2,954.60 to provide 4564857563 ! SOL IV 0.9% NACL 50ML 1 DS PWDR DRG VL. This order is part of a larger Indefinite Delivery Contract (IDC) the company holds with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen supplies a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,470.33 firm fixed-price delivery order is for the supply of a specific medical product, 4562101570 - SOL IV 0.9% NACL 100ML 1 DS PWDR DRG VL. The award does not have a set-aside designation, indicating open competition. The prime contractor, Amerisourcebergen Drug Corp, is a subsidiary of the parent company...
This federal contract award, identified as SPE2DX15D3112|SPE2DX25FDZKB, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,032.60 and an ultimate completion date of May 6, 2025. The contract is for the procurement of 4568138142 ! SOL IV 0.9% NACL 500ML PLS CNTNR VFLX LF, a medical supply item. This award is not designated as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,258.32 Firm Fixed Price delivery order contract is to provide 4567222235 SODIUM CHLORIDE 800 MEQ/200 ML 200ML, with a period of performance through February 11, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWP08
    Delivery Order

This federal contract award for $1,259.12 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4565391260 units of SOL IV 0.9% NACL 250ML PLS CNTNR VFLX LF, which are essential pharmaceutical products supporting military treatment facilities and programs.

The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities from Amerisourcebergen to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract does not have a set-aside designation and is a Firm Fixed Price arrangement with an ultimate completion date of August 9, 2024.

Generated 11/7/24, 9:32 AM